Cresco Labs Inc.
CRLBF
$0.90
-$0.05-5.22%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 151.33M | 161.55M | 164.91M | 166.12M | 165.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 151.33M | 161.55M | 164.91M | 166.12M | 165.76M |
| Cost of Revenue | 75.88M | 78.23M | 85.55M | 80.37M | 87.13M |
| Gross Profit | 75.45M | 83.32M | 79.36M | 85.75M | 78.63M |
| SG&A Expenses | 59.36M | 60.43M | 53.53M | 55.92M | 59.89M |
| Depreciation & Amortization | 4.92M | 4.97M | 5.64M | 4.42M | 5.16M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 140.15M | 143.63M | 144.72M | 140.71M | 152.17M |
| Operating Income | 11.17M | 17.93M | 20.19M | 25.41M | 13.59M |
| Income Before Tax | -2.79M | -87.15M | -10.10M | 2.74M | -918.00K |
| Income Tax Expenses | 14.22M | 1.80M | 11.87M | 16.64M | 14.32M |
| Earnings from Continuing Operations | -17.01M | -88.95M | -21.97M | -13.89M | -15.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.94M | 1.36M | 4.91M | -2.44M | 802.00K |
| Net Income | -13.07M | -87.59M | -17.05M | -16.33M | -14.43M |
| EBIT | 11.17M | 17.93M | 20.19M | 25.41M | 13.59M |
| EBITDA | 23.39M | 28.68M | 33.05M | 37.60M | 26.50M |
| EPS Basic | -0.04 | -0.24 | -0.05 | -0.05 | -0.04 |
| Normalized Basic EPS | 0.01 | 0.02 | 0.03 | 0.02 | 0.00 |
| EPS Diluted | -0.04 | -0.24 | -0.05 | -0.05 | -0.04 |
| Normalized Diluted EPS | 0.01 | 0.02 | 0.03 | 0.02 | 0.00 |
| Average Basic Shares Outstanding | 364.23M | 359.89M | 355.54M | 354.35M | 350.24M |
| Average Diluted Shares Outstanding | 364.23M | 359.89M | 355.54M | 354.35M | 350.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |